LGMN and early-onset autosomal dominant Alzheimer disease: Moreover, an increasing number of studies have suggested that legumain is involved in a variety of inflammatory diseases, such as atherosclerosis, pancreatitis, atherosclerosis, and Alzheimer's disease 30-32.